Acarbose sulfate - CAS 1221158-13-9
Catalog number: 1221158-13-9
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C25H45NO22S
Molecular Weight:
743.68
COA:
Inquire
Targets:
Others
Description:
Acarbose sulfate is an anti-diabetic drug used to treat type 2 diabetes mellitus and, in some countries, prediabetes. It is an inhibitor of alpha glucosidase, an enteric enzyme that releases glucose from larger carbohydrates. Acarbose sulfate decreased the Fasting Blood Glucose of DM Rats. The fasting blood glucose (FBG) in the acarbose-treated group decreased significantly at week 2 (P<0.05), week 4 (P<0.05), week 6 (P<0.05), and week 8 (P<0.05) compared to the DM group.
Purity:
>98%
Synonyms:
Bay-g 5421 sulfate; BAY g 5421 sulfate
MSDS:
Inquire
1.Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.
Hanjalic-Beck A1, Gabriel B, Schaefer W, Zahradnik HP, Schories M, Tempfer C, Keck C, Denschlag D. Gynecol Endocrinol. 2010 Sep;26(9):690-7. doi: 10.3109/09513591003686379.
The objective of this study was to investigate the effect of metformin versus acarbose in terms of ovulation rate, their impact on hormonal and metabolic status and tolerability of both drugs in patients with polycystic ovary syndrome (PCOS). Seventy-five patients with PCOS were included in this prospective randomised controlled double-blinded clinical study. According to randomisation, patients were allocated to receive either metformin 2550 mg/day (n = 37) or acarbose 300 mg/day (n = 38) for 12 weeks. Primary study outcomes were ovulation rate, restoration of a regular menstrual cycle and the incidence of side effects. Secondary outcomes included treatment-related hormonal and metabolic changes. Comparable high rates of regular menstrual cycles as well as ovulation could be achieved in both groups (70% and 73% for metformin vs. 78% and 59% for acarbose, p = 0.330 and p = 0.185, respectively). In contrast, only in patients treated with metformin a statistically significant decrease in fasting insulin and cholesterol levels as well as BMI was observed.
2.Absolute stereostructure of potent alpha-glucosidase inhibitor, Salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata.
Yoshikawa M1, Morikawa T, Matsuda H, Tanabe G, Muraoka O. Bioorg Med Chem. 2002 May;10(5):1547-54.
A most potent alpha-glucosidase inhibitor named salacinol has been isolated from an antidiabetic Ayurvedic traditional medicine, Salacia reticulata WIGHT, through bioassay-guided separation. The absolute stereostructure of salacinol was determined on the basis of chemical and physicochemical evidence, which included the alkaline degradation of salacinol to 1-deoxy-4-thio-D-arabinofuranose and the X-ray crystallographic analysis, to be the unique spiro-like configuration of the inner salt comprised of 1-deoxy-4-thio-D-arabinofuranosyl sulfonium cation and 1'-deoxy-D-erythrosyl-3'-sulfate anion. Salacinol showed potent inhibitory activities on several alpha-glucosidases, such as maltase, sucrase, and isomaltase, and the inhibitory effects on serum glucose levels in maltose- and sucrose-loaded rats (in vivo) were found to be more potent than that of acarbose, a commercial alpha-glucosidase inhibitor.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CDK2

CDK2, a member of the eukaryotic S/T protein kinase family, catalyzes the phosphoryl transfer of ATP γ-phosphate to serine or threonine hydroxyl (denoted as S0/...

CAS 376638-65-2 BVT-14225

BVT-14225
(CAS: 376638-65-2)

BVT-14225 is a highly selective 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor(IC50= 52 nM), which is 1,000 fold lower than that for 11β-HSD2.

DIBA
(CAS: 171744-39-1)

DIBA, a benzamide derivative, has been found to be an ER zinc finger inhibitor that could be significant in studies of breast cancers.

CAS 1515856-92-4 XEN445

XEN445
(CAS: 1515856-92-4)

XEN445 is a potent and selective endothelial lipase inhibitor with IC50 of 0.237 μM.

CAS 73-78-9 Lidocaine hydrochloride

Lidocaine hydrochloride
(CAS: 73-78-9)

Lidocaine hydrochloride is the first amino amide–type local anesthetic and antiarrhythmic drug, which has anti-inflammatory properties in vitro and in vivo. It ...

CAS 189197-69-1 Ro 48-8071 fumarate

Ro 48-8071 fumarate
(CAS: 189197-69-1)

Ro 48-8071 is an orally active cholesterol synthesis inhibitor or a 2,3-oxidosqualene:lanosterol cyclase (OSC) inhibitor. OSC (EC 5.4.99.7) represents a unique ...

CAS 297730-17-7 AVN-944

AVN-944
(CAS: 297730-17-7)

AVN-944 (VX-944) is an orally available, synthetic small molecule with potential antineoplastic activity. AVN944 inhibits inosine monosphosphate dehydrogenase (...

CAS 2002495-17-0 VU6001221

VU6001221
(CAS: 2002495-17-0)

VU6001221 is a choline transporter (CHT) inhibitor (IC50 value of 270 nM) with comparable potency for choline uptake inhibition as ML352, as well as improved PK...

Chemical Structure

CAS 1221158-13-9 Acarbose sulfate

Quick Inquiry

Verification code

Featured Items